PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30728896-8	2019	Interestingly, MK591 treatment decreases protein levels and inhibits transcriptional activities of Nanog and c-Myc.	MK 0591	15-20	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	109-114	
32313135-10	2020	We found that 5-Lox regulates c-Myc signaling in enzalutamide-resistant prostate cancer cells and inhibition of 5-Lox by Quiflapon/MK591 or shRNA interrupts oncogenic c-Myc signaling and kills ERPC cells by triggering caspase-mediated apoptosis.	MK 0591	121-130	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	167-172	
32313135-10	2020	We found that 5-Lox regulates c-Myc signaling in enzalutamide-resistant prostate cancer cells and inhibition of 5-Lox by Quiflapon/MK591 or shRNA interrupts oncogenic c-Myc signaling and kills ERPC cells by triggering caspase-mediated apoptosis.	MK 0591	131-136	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	167-172	
25875826-7	2015	Interestingly, we found that treatment with MK591 dramatically down-regulates the expression of c-Myc and its targets at sub-lethal doses.	MK 0591	44-49	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	96-101